| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716899 | Null | 0.0284045326811618 | 0.071306004 |
| NSC 718890 | Null | 0.0284045326811618 | 0.21925753 |
| NSC 720491 | Null | 0.0284045326811618 | -0.037809394 |
| NSC 721531 | Null | 0.0284045326811618 | -0.032472579 |
| NSC 730478 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-5-androsten-3.beta.,17.beta.-diol | 0.0284045326811618 | -0.089289044 |
| NSC 751958 | (2E)-2-(all-trans retinylidene)-N-{[(2E)-2-(all-trans retinylidene)hydrazinyl]carbonothioyl}hydrazinecarbothioamide N3-monosodium salt heminonahydrate | 0.0284045326811618 | 0.17503472 |
| NSC 93354 | Null | 0.0284045326811618 | 0.14312206 |
| NSC 104801 | Cytembena | 0.0286383688883668 | 0.2879391 |
| NSC 13275 | Null | 0.0286383688883668 | 0.43339789 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0286383688883668 | 0.35850906 |